Ascendis Pharma AS (ASND) Stock Price, Quote, News & History

ASNDNASDAQ
$218.06
2.461.14%
At close: Jun 12, 5:00 PM EST
$218.06
N/A
After Hours: Jun 12, 4:00 PM EST
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
60.49M
Investing Cash Flow (TTM)
-14.54M
Financing Cash Flow (TTM)
17.52M
Free Cash Flow (TTM)
52.00M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
63.47M

Analyst Trends and Forecast

6
Jan
2
Feb
2
Mar
2
Apr
4
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$14.68B
PE Ratio (TTM)
24.72
PE Ratio (FWD)
13.30
PEG Ratio (TTM)
-
PS Ratio (TTM)
13.34
PB Ratio (TTM)
25.15
Earnings Yield % (TTM)
4.05%
Earnings Yield % (FWD)
7.52%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
222.13
Book Value / Share
$8.57

Company Debt

Total Debt
$896.66M
LT Debt
$386.11M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$27.47M
Total Cash
$572.82M
Debt to Equity
1.84
Issuance of Debt (TTM)
-$27.47M
Repayment of Debt (TTM)
-$27.47M

Key Statistics

Open
$216.50
Close
$218.06
Volume / Avg.
405.01K / 639.95K
Day Range
$216.50 - $224.11
52 Wk Range
160.86 - 250.74
Market Cap
$14.30B
P/E Ratio
24.72
Dividend Yield
-
Exchange
NASDAQ
RSI
44
Short Interest
3.11%
Days to Cover
3.1

About

Sector
Health Care
Industry
Biotechnology
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Ascendis Pharma (ASND) stock?

A

You can purchase shares of Ascendis Pharma (NASDAQ:ASND) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Ascendis Pharma (ASND) competitors?

A

There are no as such competitors for Ascendis Pharma.

Q

What is the forecast, or price target, for Ascendis Pharma (ASND) stock?

A

Ascendis Pharma has a consensus price target of $274.90.

Q

What is the current price for Ascendis Pharma (ASND)?

A

The stock price for Ascendis Pharma (NASDAQ: ASND) is $218.06 last updated June 12, 2026 at 4:00 PM EDT.

Q

Does Ascendis Pharma (ASND) pay a dividend?

A

There are no upcoming dividends for Ascendis Pharma.

Q

When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?

A

Ascendis Pharma does not have any upcoming earnings scheduled.

Q

Is Ascendis Pharma (ASND) going to split?

A

There is no upcoming split for Ascendis Pharma.

Q

What sector and industry does Ascendis Pharma (ASND) operate in?

A

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.